Parallel Advisors’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.3K | Hold |
275
| – | – | ﹤0.01% | 1898 |
|
|
2025
Q1 | $24.3K | Sell |
275
-29
| -10% | -$2.57K | ﹤0.01% | 2022 |
|
|
2024
Q4 | $26.5K | Buy |
304
+18
| +6% | +$1.57K | ﹤0.01% | 1986 |
|
|
2024
Q3 | $26.5K | Buy |
286
+27
| +10% | +$2.5K | ﹤0.01% | 1924 |
|
|
2024
Q2 | $27.9K | Sell |
259
-17
| -6% | -$1.83K | ﹤0.01% | 1795 |
|
|
2024
Q1 | $26.2K | Buy |
276
+28
| +11% | +$2.66K | ﹤0.01% | 1832 |
|
|
2023
Q4 | $22.9K | Buy |
248
+118
| +91% | +$10.9K | ﹤0.01% | 1849 |
|
|
2023
Q3 | $6.53K | Buy |
130
+121
| +1,344% | +$6.08K | ﹤0.01% | 2389 |
|
|
2023
Q2 | $569 | Hold |
9
| – | – | ﹤0.01% | 3072 |
|
|
2023
Q1 | $405 | Buy |
+9
| New | +$405 | ﹤0.01% | 3166 |
|
|
2022
Q4 | – | Sell |
-6
| Closed | – | – | 3356 |
|
|
2022
Q3 | $0 | Buy |
+6
| New | – | ﹤0.01% | 3134 |
|
|
2022
Q2 | – | Sell |
-21
| Closed | -$1K | – | 2998 |
|
|
2022
Q1 | $1K | Sell |
21
-127
| -86% | -$6.05K | ﹤0.01% | 2689 |
|
|
2021
Q4 | $16K | Sell |
148
-2
| -1% | -$216 | ﹤0.01% | 1874 |
|
|
2021
Q3 | $15K | Buy |
150
+129
| +614% | +$12.9K | ﹤0.01% | 1845 |
|
|
2021
Q2 | $2K | Sell |
21
-11
| -34% | -$1.05K | ﹤0.01% | 2507 |
|
|
2021
Q1 | $3K | Buy |
32
+11
| +52% | +$1.03K | ﹤0.01% | 2323 |
|
|
2020
Q4 | $2K | Hold |
21
| – | – | ﹤0.01% | 2255 |
|
|
2020
Q3 | $2K | Hold |
21
| – | – | ﹤0.01% | 2252 |
|
|
2020
Q2 | $1K | Sell |
21
-13
| -38% | -$619 | ﹤0.01% | 2285 |
|
|
2020
Q1 | $1K | Buy |
34
+12
| +55% | +$353 | ﹤0.01% | 2232 |
|
|
2019
Q4 | $2K | Hold |
22
| – | – | ﹤0.01% | 2172 |
|
|
2019
Q3 | $2K | Hold |
22
| – | – | ﹤0.01% | 2133 |
|
|
2019
Q2 | $2K | Buy |
+22
| New | +$2K | ﹤0.01% | 2044 |
|
|
2018
Q3 | – | Sell |
-16
| Closed | -$1K | – | 2219 |
|
|
2018
Q2 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 1954 |
|